GENETIC MODIFIERS OF SICKLE CELL DISEASE

被引:21
|
作者
Thein, Swee Lay [1 ,2 ]
机构
[1] Kings Coll London, Dept Mol Haematol, James Black Ctr, London SE5 9NU, England
[2] Kings Coll Hosp Natl Hlth Serv Fdn Trust, Dept Haematol Med, London, England
关键词
Sickle cell disease; Genetic association studies; Genome-wide association studies (GWAS); FETAL-HEMOGLOBIN PRODUCTION; QUANTITATIVE-TRAIT LOCUS; GENOME-WIDE ASSOCIATION; FACTOR KLF1 CAUSES; ALPHA-THALASSEMIA; TRANSCRIPTION FACTOR; RISK-FACTOR; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; PROMOTER POLYMORPHISMS; BETA-THALASSEMIA;
D O I
10.3109/03630269.2011.615876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sickle cell disease is one of the best characterized human monogenic disorders. Complex genotype/phenotype correlations clearly demonstrate the interaction of multiple genetic and environmental factors. In the last 20 years, scientific research has applied genetic approaches to dissect some of these modifiers. This review highlights the more recent genetic association studies that have been applied to unravel the genetic modifiers of sickle cell disease including Hb F genetics, and the key genetic variants identified. Illumination of such modifying factors may guide future therapeutic interventions and improve prediction of disease severity, with implications for genetic counseling, prenatal diagnosis and implementation of high risk therapy.
引用
收藏
页码:589 / 606
页数:18
相关论文
共 50 条
  • [1] Genetic modifiers of sickle cell disease
    Steinberg, Martin H.
    Sebastiani, Paola
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (08) : 795 - 803
  • [2] Genetic Modifiers of Sickle Cell Disease
    Pincez, Thomas
    Ashley-Koch, Allison E.
    Lettre, Guillaume
    Telen, Marilyn J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (06) : 1097 - 1124
  • [3] Genetic modifiers of severity in sickle cell disease
    Chang, Alicia K.
    Summarell, Carly C. Ginter
    Birdie, Parendi T.
    Sheehan, Vivien A.
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2018, 68 (2-3) : 147 - 164
  • [4] Genetic modifiers of homozygous sickle cell disease
    Hartmann, K
    Kulozik, AE
    KLINISCHE PADIATRIE, 2006, 218 (03): : 170 - 173
  • [5] Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease
    Thein, Swee Lay
    GENE AND CELL THERAPIES FOR BETA-GLOBINOPATHIES, 2017, 1013 : 27 - 57
  • [6] Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease
    Stephan Menzel
    Swee Lay Thein
    Molecular Diagnosis & Therapy, 2019, 23 : 235 - 244
  • [7] Genetic Modifiers of Iron Overload in Sickle Cell Disease
    Puri, Latika
    Hankins, Jane
    Hillenbrand, Claudia
    Flanagan, Jonathan
    Kang, Guolian
    Bi, Wenjian
    Tipirneni-Sajja, Aaryani
    Villavicencio, Martha
    Loeffler, Ralf
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S24 - S25
  • [8] Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease
    Menzel, Stephan
    Thein, Swee Lay
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (02) : 235 - 244
  • [9] Pathophysiology of sickle cell disease: Role of cellular and genetic modifiers
    Steinberg, MH
    Rodgers, GP
    SEMINARS IN HEMATOLOGY, 2001, 38 (04) : 299 - 306
  • [10] Genetic Modifiers of HbF and Response to Hydroxyurea in Sickle Cell Disease
    Green, Nancy S.
    Barral, Sandra
    PEDIATRIC BLOOD & CANCER, 2011, 56 (02) : 177 - 181